Hematologic Malignancy
Acute Leukemia
CI-CAN-00000399Explore in graph →
Hematologic1,259 active trials30 approved drugs323 evidence items
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000399Explore in graph →
Clinical trials
4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (718)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06188182 | D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia | unknown | — | 60 | Assiut UniversityOTHER | 0 | Jan 3, 2024 | clinicaltrials |
| NCT05846672 | Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List" | unknown | — | 200 | Istanbul University - CerrahpasaOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT06162325 | Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients | unknown | — | 45 | Peking Union Medical College HospitalOTHER | 1 | Dec 8, 2023 | clinicaltrials |
| NCT06160115 | The Role of NK Cells to Detect Blood Infection in ALL. | unknown | — | 56 | Assiut UniversityOTHER | 0 | Dec 7, 2023 | clinicaltrials |
| NCT03064269 | CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia | unknown | Phase 1 | 10 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | Nov 29, 2023 | clinicaltrials |
| NCT03896854 | CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) | unknown | Phase 1 / Phase 2 | 15 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | Nov 29, 2023 | clinicaltrials |
| NCT04257175 | CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression | unknown | Phase 2 / Phase 3 | 10 | Sheba Medical CenterOTHER_GOV | 1 | Nov 28, 2023 | clinicaltrials |
| NCT04989335 | Bisantrene Combination for Resistant AML | unknown | Phase 2 | 29 | Sheba Medical CenterOTHER_GOV | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05025150 | Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial | unknown | — | 1,020 | Sutter HealthOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT05747157 | Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research | unknown | Early Phase 1 | 18 | Anhui Provincial HospitalOTHER_GOV | 1 | Nov 21, 2023 | clinicaltrials |
| NCT05918198 | Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia | unknown | Phase 2 | 52 | Peking University People's HospitalOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT06141304 | Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT | unknown | Phase 2 | 28 | The First Hospital of Jilin UniversityOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT06087419 | A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients | unknown | Phase 1 / Phase 2 | 42 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Nov 2, 2023 | clinicaltrials |
| NCT06110182 | Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia | unknown | — | 300 | Central Hospital, Nancy, FranceOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04767152 | Evaluation of Brain Changes in ALL Patients on Therapy | unknown | N/A | 110 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT06105658 | Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML | unknown | Phase 2 | 20 | Anhui Provincial HospitalOTHER_GOV | 1 | Oct 30, 2023 | clinicaltrials |
| NCT06107478 | Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages"(MASSAYA) | unknown | — | 181 | Centre Leon BerardOTHER | 0 | Oct 30, 2023 | clinicaltrials |
| NCT04964518 | A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) | unknown | Phase 1 / Phase 2 | 24 | Ascentage Pharma Group Inc.INDUSTRY | 2 | Oct 25, 2023 | clinicaltrials |
| NCT06056752 | QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia | unknown | Phase 1 | 10 | Anhui Provincial HospitalOTHER_GOV | 1 | Oct 24, 2023 | clinicaltrials |
| NCT06026839 | Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors | unknown | — | 250 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT06092203 | Quality of Life for Pediatric Urolithiasis(Elattar) | unknown | — | 100 | Mansoura UniversityOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT05504408 | Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia | unknown | — | 200 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06067321 | Gastric Residual Volumes in Infants Fed at 4 and 6 Hours Prior to General Anaesthesia | unknown | N/A | 70 | King's College Hospital NHS TrustOTHER | 1 | Oct 4, 2023 | clinicaltrials |
| NCT06060431 | Effectiveness of a Pain Science Education Programme in Adolescent Students.(EDEA) | unknown | N/A | 293 | University Rovira i VirgiliOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT06049667 | A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies | unknown | Phase 1 | 72 | Nanjing Chia-tai Tianqing PharmaceuticalINDUSTRY | 1 | Sep 22, 2023 | clinicaltrials |
| NCT05801835 | A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for Injection | unknown | N/A | 36 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.INDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT03709914 | PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)(Pediatric_PK) | unknown | Phase 1 | 21 | Nabriva Therapeutics AGINDUSTRY | 1 | Sep 15, 2023 | clinicaltrials |
| NCT06027853 | Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia | unknown | Phase 1 | 24 | Zhejiang UniversityOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT06008405 | Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy | unknown | Phase 1 | 48 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05973162 | Effects of Virtual Reality in Pediatric Burn Patients | unknown | N/A | 30 | Riphah International UniversityOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT06018324 | CloudCare in the Treatment of Type 1 Diabetes in Pediatrics | unknown | — | 600 | Diabeter Nederland BVOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT03962465 | Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL(ALL-001) | unknown | Phase 1 | 36 | University of VirginiaOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT05983172 | Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia | unknown | — | 1,500 | National Taiwan University HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05982756 | Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML | unknown | Phase 1 | 40 | Zhongnan HospitalOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT03867682 | Venetoclax and Lintuzumab-Ac225 in AML Patients | unknown | Phase 1 / Phase 2 | 38 | Actinium PharmaceuticalsINDUSTRY | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05977387 | Pediatric Kidney Transplant(PeKiT) | unknown | — | 500 | Imagine InstituteOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05226468 | An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia | unknown | Phase 1 | 24 | New Epsilon Innovation LimitedINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05313958 | Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children(SCCLG-M5) | unknown | Phase 2 / Phase 3 | 43 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05951855 | Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients | unknown | Phase 2 | 42 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Jul 19, 2023 | clinicaltrials |
| NCT05949762 | Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly | unknown | Phase 1 / Phase 2 | 45 | ZePing ZhouOTHER | 1 | Jul 18, 2023 | clinicaltrials |
| NCT05950204 | Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia. | unknown | N/A | 40 | Coordinación de Investigación en Salud, MexicoOTHER_GOV | 1 | Jul 18, 2023 | clinicaltrials |
| NCT04923919 | Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia | unknown | Early Phase 1 | 100 | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05943093 | H19 in Acute Lymphoblastic Leukemia. | unknown | — | 96 | Assiut UniversityOTHER | 0 | Jul 13, 2023 | clinicaltrials |
| NCT05919199 | PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia(FDG-PETAML) | unknown | — | 60 | First Affiliated Hospital of Jinan UniversityOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05893472 | A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML. | unknown | Phase 1 / Phase 2 | 45 | ZePing ZhouOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05264883 | Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML | unknown | Phase 3 | 170 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05639673 | Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia | unknown | — | 5,000 | Rigshospitalet, DenmarkOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT05140811 | A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | unknown | Phase 1 / Phase 2 | 126 | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.OTHER | 1 | May 24, 2023 | clinicaltrials |
| NCT05303155 | The Association of Gut Microbiota With COVID 19 Infection in Children | unknown | — | 40 | Hallym University Kangnam Sacred Heart HospitalOTHER | 1 | May 19, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Jan 3, 2024source: clinicaltrials